Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

NCT01605084 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

HIV

Interventions

DRUG: Atazanavir
DRUG: Darunavir
DRUG: Ritonavir
DRUG: Optimized NRTI backbone

Sponsor

Bristol-Myers Squibb